Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combined treatment for PTSD and chronic pain

Official title: Pilot of an Integrated Treatment for Comorbid PTSD and Chronic Pain

Run by Weill Medical College of Cornell University · NCT07225049 · Data updated 2026-11-12

This project will try a combined therapy that treats PTSD and long-term pain at the same time for adults who have both conditions.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedDecember 8, 2025
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedJune 15, 2026
Trial IDNCT07225049 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older who speak English, meet CAPS-5 criteria for PTSD, report chronic pain severity of 4/10 or higher over the past three months, are medically stable, and have had stable psychotropic medications for at least 60 days are the intended participants.

Probably not a fit

People with a lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder, those with moderate to severe recent substance use, those currently receiving evidence-based PTSD or pain psychotherapy, or those with significant cognitive impairment are unlikely to benefit from or be eligible for this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm pilot testing an integrated intervention that delivers evidence-based PTSD therapy (Prolonged Exposure) together with cognitive-behavioral therapy for chronic pain, rather than offering them one after the other. Adults who meet diagnostic criteria for PTSD and report clinically meaningful chronic pain will receive the combined protocol while remaining on stable medications. Outcomes will include changes in PTSD symptoms, pain severity, functional impairment, and treatment retention to gauge feasibility and preliminary efficacy. The work is conducted at Weill Cornell Medicine with in-person outpatient therapy visits.

Why it matters

Potential benefit: If successful, delivering PTSD and pain treatment together could reduce both symptoms more efficiently and lower dropout compared with treating each condition separately.

How similar studies have gone: Gold-standard treatments like Prolonged Exposure and CBT for chronic pain are effective individually, but simultaneous integrated approaches are relatively novel and have limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* English-speaking
* Currently meets criteria for PTSD, assessed by the CAPS-5 (any trauma type) - Chronic pain, assessed by greater than or equal to 4 on a scale of 0-10 pain severity over the past 3 months
* Medically stable at the time of study enrollment (chronic illness and disability does not prevent attendance of outpatient therapy sessions)
* Stable on psychotropic medication for past 60 days
* Agreed to not change current medication or pain-related treatments over the course of the study unless medically necessary
* Must be located in the state of New York for virtual assessments and treatment sessions

Exclusion Criteria:

* Lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder
* Participation in concurrent evidence-based psychological treatment for PTSD or chronic pain during the past 3 months
* Participants must not participate in an evidence-based psychological treatment for either PTSD or pain during the course of the study.
* Moderate or severe substance use in the past 90 days
* Cognitive impairment to the degree that the patient cannot provide informed consent or fill out assessment measures
* Participants who in the PI's judgement pose a current homicidal or suicidal risk

Where it's running

  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: JoAnn Difede, PhD — Weill Medical College of Cornell University
  • Study coordinator: Mariel Emrich, MS
  • Email: mae2050@med.cornell.edu
  • Phone: 212-821-0783

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.